MJ Holdings Inc (MJNE)
0.0001
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
MJ Holdings Max Drawdown (5Y): 99.99% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 99.99% |
September 30, 2024 | 99.99% |
August 31, 2024 | 99.99% |
July 31, 2024 | 99.99% |
June 30, 2024 | 99.81% |
May 31, 2024 | 99.81% |
April 30, 2024 | 99.81% |
March 31, 2024 | 99.81% |
February 29, 2024 | 99.81% |
January 31, 2024 | 99.81% |
December 31, 2023 | 99.81% |
November 30, 2023 | 99.81% |
October 31, 2023 | 99.81% |
September 30, 2023 | 99.81% |
August 31, 2023 | 99.81% |
July 31, 2023 | 99.81% |
June 30, 2023 | 99.81% |
May 31, 2023 | 99.74% |
April 30, 2023 | 99.00% |
March 31, 2023 | 98.91% |
February 28, 2023 | 98.91% |
January 31, 2023 | 98.91% |
December 31, 2022 | 98.91% |
November 30, 2022 | 98.91% |
October 31, 2022 | 98.91% |
Date | Value |
---|---|
September 30, 2022 | 98.91% |
August 31, 2022 | 98.91% |
July 31, 2022 | 98.91% |
June 30, 2022 | 98.91% |
May 31, 2022 | 98.91% |
April 30, 2022 | 98.91% |
March 31, 2022 | 98.91% |
February 28, 2022 | 98.91% |
January 31, 2022 | 98.91% |
December 31, 2021 | 98.91% |
November 30, 2021 | 98.91% |
October 31, 2021 | 98.91% |
September 30, 2021 | 98.91% |
August 31, 2021 | 98.91% |
July 31, 2021 | 98.91% |
June 30, 2021 | 98.91% |
May 31, 2021 | 98.91% |
April 30, 2021 | 98.91% |
March 31, 2021 | 98.91% |
February 28, 2021 | 98.91% |
January 31, 2021 | 98.91% |
December 31, 2020 | 98.91% |
November 30, 2020 | 98.91% |
October 31, 2020 | 98.91% |
September 30, 2020 | 98.91% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.08%
Minimum
Nov 2019
99.99%
Maximum
Jul 2024
99.10%
Average
98.91%
Median
Sep 2020
Max Drawdown (5Y) Benchmarks
Ampio Pharmaceuticals Inc | 100.0% |
FluoroPharma Medical Inc | 100.00% |
Evolutionary Genomics Inc | 99.96% |
Xeno Transplants Corp | 100.00% |
Entia Biosciences Inc | 99.95% |